CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...